Abstract：
:Colorectal cancer ranks third in incidence in both men and women after lung, breast and prostate cancer. The prevalence of colorectal cancer increases significantly with age, with 40% of patients in Europe being >75 years of age at the time of initial diagnosis. Furthermore, the number of elderly patients with colorectal cancer is expected to increase significantly over the next two decades. Treatment of advanced colorectal cancer has evolved dramatically over the last decade. Advances in surgery and chemotherapy are effective in prolonging time to disease progression and survival in patients with advanced colorectal cancer. For >40 years, fluorouracil has been the mainstay of chemotherapy for advanced colorectal cancer. Recently, however, newer cytotoxic chemotherapies and biological agents effective against colorectal cancer have been shown to improve overall survival in metastatic disease. Thus, a patient with metastatic colorectal cancer today has an expected median survival of 20 months compared with 10 months only a few years ago. There is evidence that elderly individuals derive as much survival benefit from standard chemotherapy approaches in metastatic colorectal cancer as younger patients. Unfortunately, most older patients who might benefit from chemotherapy are not offered this treatment, and the fraction who are not offered it increases with increasing age. Treatment decisions should not be made on the basis of age. Rather, they should be based on functional status, the presence of co-morbidities, and consideration of drug-specific toxicities that can be aggravated in older individuals because of decreased functional reserve. Although the elderly have been under-represented in clinical trials, studies also support the effectiveness of combination chemotherapy in elderly patients with advanced colorectal cancer. This article reviews current optimal first-line treatment strategies for elderly patients with metastatic colorectal cancer.
journal_name
Drugs Agingjournal_title
Drugs & agingauthors
Meulenbeld HJ,Creemers GJdoi
10.2165/00002512-200724030-00004subject
Has Abstractpub_date
2007-01-01 00:00:00pages
223-38issue
3eissn
1170-229Xissn
1179-1969pii
2434journal_volume
24pub_type
杂志文章,评审相关文献
DRUGS & AGING文献大全abstract：BACKGROUND:In the presence of multimorbidity and limited life expectancy (LLE), the need for continued use of preventive medicines becomes uncertain as they may neither improve health nor confer continued health benefits. OBJECTIVE:Our objective was to systematically review the literature to examine the discontinuatio...
journal_title：Drugs & aging
pub_type： 杂志文章,评审
doi：10.1007/s40266-017-0487-1
更新日期：2017-10-01 00:00:00
abstract：:The incidence of prostate carcinoma in the US now appears to be declining slightly, as a consequence of removal of prevalent cases from the population by screening. Screening for serum prostate-specific antigen (PSA) levels has been improved by the use of PSA transformations including PSA density, PSA velocity and age...
journal_title：Drugs & aging
pub_type： 杂志文章,评审
doi：10.2165/00002512-199813010-00007
更新日期：1998-07-01 00:00:00
abstract：:NSAIDs are a widely used class of analgesic and anti-inflammatory drugs that act by inhibiting the cyclo-oxygenase (COX) enzyme. However, because of their nonspecificity of action, use of these agents as long-term therapy for chronic pain in diseases such as rheumatoid arthritis (RA) and osteoarthritis (OA) is often d...
journal_title：Drugs & aging
pub_type： 杂志文章,评审
doi：10.2165/00002512-200724060-00001
更新日期：2007-01-01 00:00:00
abstract：:Electronic storage of and access to medical data is becoming increasingly common. Advances in computer technology and telecommunications have made it possible to store vast amounts of information in databases and transmit this information rapidly to any place on the globe. At the forefront of this technology is the In...
journal_title：Drugs & aging
pub_type： 杂志文章,评审
doi：10.2165/00002512-199710030-00001
更新日期：1997-03-01 00:00:00
abstract：:High drug consumption among the elderly and inappropriate prescribing practices increase the risk of adverse drug effects in this population. This risk may be decreased by conducting, for example, a medication review alone or as part of a comprehensive geriatric assessment (CGA); however, little is known about the fat...
journal_title：Drugs & aging
pub_type： 杂志文章,随机对照试验
doi：10.2165/11536650-000000000-00000
更新日期：2010-06-01 00:00:00
abstract：BACKGROUND:Age-related changes in the concentration-effect relationship of (+)-O-desmethyl-tramadol [(+)-ODM], tramadol's active metabolite, are not documented in the elderly. OBJECTIVE:The objective of this study was to characterize, in elderly and young subjects, the (+)-ODM pharmacokinetic and pharmacodynamic relat...
journal_title：Drugs & aging
pub_type： 杂志文章,随机对照试验
doi：10.1007/s40266-019-00681-w
更新日期：2019-08-01 00:00:00
abstract：BACKGROUND:The choice of induction immunosuppression for kidney transplantation in elderly recipients is dictated by the consideration of the risk of infection as well as efficacy in the prevention of acute rejection, thus allowing a reduction in subsequent maintenance immunosuppression and its attendant long-term adve...
journal_title：Drugs & aging
pub_type： 杂志文章
doi：10.2165/00002512-200421110-00005
更新日期：2004-01-01 00:00:00
abstract：BACKGROUND:The importance of optimising medicines management for people with dementia has been emphasised through research and policy. However, evidence is currently lacking regarding how to achieve this in this patient population. OBJECTIVE:The aim was to assess the effectiveness of medicines management interventions...
journal_title：Drugs & aging
pub_type： 杂志文章,评审
doi：10.1007/s40266-017-0505-3
更新日期：2017-12-01 00:00:00
abstract：:Dopamine agonists (DAs) are frequently used in the management of Parkinson's disease (PD), a complex multisystem disorder influenced substantially by age-related factors. Over 80% of PD patients present after age 60 years and may have clinical features exacerbated by age-related comorbidities or decline in physiologic...
journal_title：Drugs & aging
pub_type： 杂志文章
doi：10.1007/s40266-018-0629-0
更新日期：2019-03-01 00:00:00
abstract：:The incidence of both systolic and diastolic hypertension is increased in elderly patients, therefore antihypertensive drugs are commonly used in this population. In addition to changes in blood pressure, the aging process also causes numerous changes in other physiological parameters, resulting in altered pharmacokin...
journal_title：Drugs & aging
pub_type： 杂志文章,评审
doi：10.2165/00002512-199101030-00004
更新日期：1991-05-01 00:00:00
abstract：:Osteoporosis is a common disease that affects 1 in 3 women. Family and twin studies have demonstrated that there is a strong genetic component to this condition. Potential candidate genes examined for their regulatory effect on bone mass include those for collagen type I, estrogen and vitamin D receptors, and various ...
journal_title：Drugs & aging
pub_type： 杂志文章,评审
doi：10.2165/00002512-199711050-00001
更新日期：1997-11-01 00:00:00
abstract：:The Medicare programme already funds a large proportion of the medical care for older Americans. However, geriatricians are an underutilized resource for improving the quality of care delivered with Medicare funding, particularly to the most complex patients. Recent legislative changes will increase the involvement of...
journal_title：Drugs & aging
pub_type： 杂志文章,评审
doi：10.2165/00002512-200522050-00002
更新日期：2005-01-01 00:00:00
abstract：BACKGROUND:Older people are often prescribed multiple drugs with sedative properties. Most research has focused on specific classes of sedative and psychotropic drugs. The cumulative effect of taking multiple drugs with sedative properties has been termed 'sedative load'. Few previous studies have investigated the seda...
journal_title：Drugs & aging
pub_type： 临床试验,杂志文章
doi：10.2165/11317080-000000000-00000
更新日期：2009-01-01 00:00:00
abstract：:Persons over the age of 65 years are the fastest growing segment of the US population. In the next 30 years this segment will represent more than 20% of the population. Fifty percent of all cancers occur in this age group and therefore the total cancer burden is expected to rise. Data are becoming available that will ...
journal_title：Drugs & aging
pub_type： 杂志文章,评审
doi：10.2165/00002512-200320100-00003
更新日期：2003-01-01 00:00:00
abstract：:Mild hypertension (grade 1 or stage 1 hypertension) is defined as a systolic blood pressure of 140-159 mm Hg or a diastolic pressure of 90-99 mm Hg. According to current guidelines, patients with mild hypertension can be at low, medium, high or very high risk depending on the presence of other risk factors, target org...
journal_title：Drugs & aging
pub_type： 杂志文章,评审
doi：10.2165/00002512-200421010-00001
更新日期：2004-01-01 00:00:00
abstract：BACKGROUND AND OBJECTIVE:Osteoarthritis (OA) is a highly prevalent and chronic condition characterized by pain and physical disability. Currently, many treatments are available, and they primarily target pain relief. The objectives of this study were to systematically review economic evaluations for pharmaceutical mana...
journal_title：Drugs & aging
pub_type： 杂志文章,评审
doi：10.1007/s40266-013-0062-3
更新日期：2013-05-01 00:00:00
abstract：:The median age for breast cancer diagnosis is 62 years, but a disproportionate number of patients are over the age of 75 years and the majority of those have hormone receptor-positive, human epidermal growth factor receptor-2 (HER2)-negative cancers. This review provides a logical algorithm to guide providers through ...
journal_title：Drugs & aging
pub_type： 杂志文章,评审
doi：10.1007/s40266-020-00748-z
更新日期：2020-05-01 00:00:00
abstract：:Urothelial carcinoma, or bladder cancer, is a malignancy that most commonly affects older patients. The median age at diagnosis is 73 years, and care of these patients requires consideration not just of the disease-related factors such as stage and histology, but also of patient-related factors. Many of these patients...
journal_title：Drugs & aging
pub_type： 杂志文章,评审
doi：10.1007/s40266-018-0540-8
更新日期：2018-05-01 00:00:00
abstract：:Erectile dysfunction (ED) is a common medical condition that affects the sexual life of millions of men worldwide. First-line oral therapy for ED includes the use of phosphodiesterase type 5 inhibitors (sildenafil, tadalafil and vardenafil) and sublingual apomorphine. Apomorphine is a dopamine D(1) and D(2) receptor a...
journal_title：Drugs & aging
pub_type： 杂志文章,评审
doi：10.2165/00002512-200623040-00004
更新日期：2006-01-01 00:00:00
abstract：:The fluoroquinolones are antibiotics frequently used in infections that affect elderly individuals. The physiological aging process can profoundly affect the pharmacokinetics of drugs, necessitating adjustment of dosage regimens in the elderly. Changes in pharmacokinetics with age are mainly due to the progressive det...
journal_title：Drugs & aging
pub_type： 杂志文章,评审
doi：10.2165/00002512-199101040-00004
更新日期：1991-07-01 00:00:00
abstract：:Influenza is a major cause of morbidity and mortality in the elderly. Influenza vaccine is recommended for people aged 65 years and older and those in long term care. Currently only 30% of high risk persons are vaccinated. Vaccination generally stimulates an adequate immune response, is well tolerated and is to be enc...
journal_title：Drugs & aging
pub_type： 杂志文章,评审
doi：10.2165/00002512-199101060-00003
更新日期：1991-11-01 00:00:00
abstract：BACKGROUND:Withdrawal of fall-risk-increasing drugs has been proven to be effective in older persons. However, given the enormous rise in healthcare costs in recent decades, the effect of such withdrawals on healthcare costs also needs to be considered. METHOD:Within a common geriatric outpatient population, patients ...
journal_title：Drugs & aging
pub_type： 杂志文章
doi：10.2165/00002512-200825060-00005
更新日期：2008-01-01 00:00:00
abstract：:Atrial fibrillation confers a 5-fold increase in risk of stroke. A number of drugs aimed at reducing this risk have been tested in randomized controlled trials. These include antiplatelet agents (singly and in combination); anticoagulants, including vitamin K antagonists and direct thrombin inhibitors; and anticoagula...
journal_title：Drugs & aging
pub_type： 杂志文章,评审
doi：10.2165/11538620-000000000-00000
更新日期：2010-11-01 00:00:00
abstract：BACKGROUND:Evidence regarding differences in outcomes between angiotensin II receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEIs) among older nursing home (NH) residents after acute myocardial infarction (AMI) is limited. OBJECTIVES:The purpose of our study was to estimate the post-AMI effects...
journal_title：Drugs & aging
pub_type： 杂志文章
doi：10.1007/s40266-020-00791-w
更新日期：2020-10-01 00:00:00
abstract：:The focus of this review is hormone replacement therapy (HRT) with continuous oral 17 beta-estradiol (herein referred to as estradiol) 2 mg/day plus sequential oral dydrogesterone 10 or 20 mg/day for 14 days of each 28-day cycle. According to data from nonblind trials, this regimen relieves climacteric symptoms, prese...
journal_title：Drugs & aging
pub_type： 杂志文章,评审
doi：10.2165/00002512-199711040-00006
更新日期：1997-10-01 00:00:00
abstract：BACKGROUND:In response to concerns about, and issues pertaining to, medication use practices in residential aged-care facilities (RACFs), the Australian Pharmaceutical Advisory Council (APAC) established a working party on quality use of medicines (QUM) in nursing homes and hostels. The APAC is a representative ministe...
journal_title：Drugs & aging
pub_type： 杂志文章,评审
doi：10.2165/00002512-200421120-00005
更新日期：2004-01-01 00:00:00
abstract：BACKGROUND:Medication for elderly patients is often complex and problematic. Several criteria for classifying inappropriate prescribing exist. In 2010, the Swedish National Board of Health and Welfare published the document "Indicators of appropriate drug therapy in the elderly" as a guideline for improving prescribing...
journal_title：Drugs & aging
pub_type： 杂志文章
doi：10.1007/s40266-014-0165-5
更新日期：2014-05-01 00:00:00
abstract：BACKGROUND:Several studies have shown that the mortality of elderly hip fracture patients is higher than that in the general population, and is higher in male than in female hip fracture patients. OBJECTIVE:The objective of this study was to investigate factors affecting overall mortality at a minimum of 11 years foll...
journal_title：Drugs & aging
pub_type： 杂志文章
doi：10.1007/s40266-015-0267-8
更新日期：2015-06-01 00:00:00
abstract：BACKGROUND:Glaucoma comprises age-related neurodegenerative diseases of retinal ganglion cells, the worldwide prevalence of which is increasing. Local pharmacotherapy is the primary treatment option, especially in the elderly. But this therapeutic approach may include risks for adverse drug effects and drug-drug intera...
journal_title：Drugs & aging
pub_type： 杂志文章
doi：10.1007/s40266-012-0036-x
更新日期：2013-01-01 00:00:00
abstract：:Alzheimer's disease is the most common major neurocognitive disorder with substantial social and economic impacts. This article is an update on current pharmacotherapy, advancements in biomarker use, and drugs in the pipeline for this disease. To date, no new drug has qualified to be added to the current therapeutic a...
journal_title：Drugs & aging
pub_type： 杂志文章,评审
doi：10.1007/s40266-017-0499-x
更新日期：2017-11-01 00:00:00
